Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Great Post Regarding Dr. Santosh Kesari, M.D., Ph.D....

...a world renowned Micro Biologist AND Neuro-Oncologist who participated in the development of RGBP's "Immune Checkpoint" NR2F6 Patent associated with the correlation between inhibition of NR2F6 for immune stimulation and gene silencing.

NR2F6 is a molecular switch known as an "orphan nuclear receptor", which controls genes associated with the immune response as well as genes associated with the ability of cancer stem cells to propagate. Regen has filed numerous patent applications covering means of manipulating NR2F6 in oncology and immunology. Issued US Patent # 9091696B2 was assigned to Regen BioPharma.

Regen Biopharma reported that the gene silencing capacity of NR2F6 leads to induction of cancer stem cell differentiation which is a process that renders Malignant Cancer cells to become Benign.

Other words SWITCHING OFF MALIGNANT CANCER CELLS DEAD IN THEIR TRACKS!

https://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+Identifies+Small+Molecule+Drug+Candidates+Targeting+Its+Proprietary+Immune+Checkpoint+NR2F6/11157880.html

This Patent in and of itself ALL by itself has a Multi-Billion Dollar Market Capacity just like ALL of RGBP's other Patents!

But yet the Crooked Naked Short Selling Counterfeiting Market Makers would have everyone think that ALL of RGBP's 24 Patents aren't even worth 2 CENTS!!! HA! HOW ROARING HILARIOUS! Anyone who believes this CON I have a Bridge in Arizona and a Flying Turtle I'd like to sell you!

Be well and prosper...